wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q28044590-88A4C0AB-79C9-4A76-BFF6-72C671D856A0
Q28044590-88A4C0AB-79C9-4A76-BFF6-72C671D856A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28044590-88A4C0AB-79C9-4A76-BFF6-72C671D856A0
Overcoming mutation-based resistance to antiandrogens with rational drug design
P2860
Q28044590-88A4C0AB-79C9-4A76-BFF6-72C671D856A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28044590-88A4C0AB-79C9-4A76-BFF6-72C671D856A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c7c56657dc45b1e421ad0be204b0a81a2073ef1
P2860
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency